Nucleus Biotech GmbH provides enabling reagents and services to life science researchers in academia and industry. Cutting edge reagents, competent advice and in-depth knowledge of customer requirements, both in day-to-day laboratory work and for particularly challenging issues, are the company's main strengths. 

Nucleus Biotech sources companies that develop and market the latest reagents and methods to make them available to you, our valuable customers. Cellecta (California, USA) are our resource of lentiviral sgRNA-, shRNA-, and barcode- libraries for CRISPR- and RNAi-based target screenings and cellular barcoding. Readouts are performed by Next Generation Sequencing (NGS), available in kit format or as customized service. Further highly innovative NGS-based methods in the portfolio are Hi-C Sequencing for 3-dimensional genome studies, TELL-Seq for long range sequencing on short read sequencers by linked-reads, TCR/BCR-seq for Adaptive Immune Receptor Profiling, and BioliqX Small RNA-seq for analysis of picogram amounts of cell-free RNA in liquid biopsy samples - developed by our local partner Heidelberg Biolabs.

Nucleus Biotech GmbH is based in Heidelberg/Germany, one of the hot spots for life sciences research in Germany. The company addresses customers throughout the European Union, for some distribution lines restricted to Germany, Austria, and Switzerland.

Nucleus Biotech GmbH

Org chart

Teams

Offices